Page 1 | Search Results | Blood Advances | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Spotlight on eltrombopag in pediatric ITP in China: a long-term observational study in real-world practice

Xiaoling Cheng, LingLing Fu, Jingyao Ma, Hao Gu, Zhenping Chen, Libo Zhao, Xiaoling Wang, Runhui Wu

Blood Adv (2021) 5 (19): 3799–3806.

https://doi.org/10.1182/bloodadvances.2020004110

Published: 2021

Journal Articles

Autoimmune- and complement-mediated hematologic condition recrudescence following SARS-CoV-2 vaccination

Andrew Jay Portuguese, Cassandra Sunga, Rebecca Kruse-Jarres, Terry Gernsheimer, Janis Abkowitz

Blood Adv (2021) 5 (13): 2794–2798.

https://doi.org/10.1182/bloodadvances.2021004957

Published: 2021

Journal Articles

Misdiagnosed thrombocytopenia in children and adolescents: analysis of the Pediatric and Adult Registry on Chronic ITP

Alexandra Schifferli, Andrea Heiri, Paul Imbach, Susanne Holzhauer, Markus G. Seidel, Diane Nugent, Marc Michel, Thomas Kühne

Blood Adv (2021) 5 (6): 1617–1626.

https://doi.org/10.1182/bloodadvances.2020003004

Published: 2021

Journal Articles

Phase 2 multiple-dose study of an FcRn inhibitor, rozanolixizumab, in patients with primary immune thrombocytopenia

Tadeusz Robak, Maciej Kaźmierczak, Isidro Jarque, Vasile Musteata, Jacek Treliński, Nichola Cooper, Peter Kiessling, Ute Massow, Franz Woltering, Rose Snipes, Juan Ke, Grant Langdon, James B. Bussel, Stephen Jolles

Blood Adv (2020) 4 (17): 4136–4146.

https://doi.org/10.1182/bloodadvances.2020002003

Published: 2020

Includes: Supplemental data

Journal Articles

Platelet autoantibodies in the bone marrow of patients with immune thrombocytopenia

Sabrina Shrestha, Ishac Nazy, James W. Smith, John G. Kelton, Donald M. Arnold

Blood Adv (2020) 4 (13): 2962–2966.

https://doi.org/10.1182/bloodadvances.2020001846

Published: 2020

Includes: Supplemental data

Journal Articles

Significance of antinuclear antibodies in primary immune thrombocytopenia: results of the CARMEN registry

Guillaume Moulis, Thibault Comont, Johanne Germain, Agnès Sommet, Maryse Lapeyre-Mestre, Odile Beyne-Rauzy, Daniel Adoue, and the CARMEN investigators group

Blood Adv (2020) 4 (9): 1974–1977.

https://doi.org/10.1182/bloodadvances.2020001664

Published: 2020

Includes: Supplemental data

Journal Articles

Risk factors for skin, mucosal, and organ bleeding in adults with primary ITP: a nationwide study in Japan

Takaaki Hato, Naoki Shimada, Yoshiyuki Kurata, Masataka Kuwana, Kingo Fujimura, Hirokazu Kashiwagi, Toshiro Takafuta, Mitsuru Murata, Yoshiaki Tomiyama

Blood Adv (2020) 4 (8): 1648–1655.

https://doi.org/10.1182/bloodadvances.2020001446

Published: 2020

Journal Articles

IVMP+IVIG raises platelet counts faster than IVIG alone: results of a randomized, blinded trial in childhood ITP

Manuel Carcao, Mariana Silva, Michele David, Robert J. Klaassen, MacGregor Steele, Victoria Price, Cindy Wakefield, Lussia Kim, Derek Stephens, Victor S. Blanchette

Blood Adv (2020) 4 (7): 1492–1500.

https://doi.org/10.1182/bloodadvances.2019001343

Published: 2020

Includes: Supplemental data

Journal Articles

A modern reassessment of glycoprotein-specific direct platelet autoantibody testing in immune thrombocytopenia

Hanny Al-Samkari, Rachel P. Rosovsky, Rebecca S. Karp Leaf, David B. Smith, Katayoon Goodarzi, Annemarie E. Fogerty, David B. Sykes, David J. Kuter

Blood Adv (2019) 4 (1): 9–18.

https://doi.org/10.1182/bloodadvances.2019000868

Published: 2019

Includes: Supplemental data

Journal Articles

American Society of Hematology 2019 guidelines for immune thrombocytopenia

Cindy Neunert, Deirdra R. Terrell, Donald M. Arnold, George Buchanan, Douglas B. Cines, Nichola Cooper, Adam Cuker, Jenny M. Despotovic, James N. George, Rachael F. Grace, Thomas Kühne, David J. Kuter, Wendy Lim, Keith R. McCrae, Barbara Pruitt, Hayley Shimanek, Sara K. Vesely

Blood Adv (2019) 3 (23): 3829–3866.

https://doi.org/10.1182/bloodadvances.2019000966

Published: 2019

Includes: Supplemental data

Journal Articles

Updated international consensus report on the investigation and management of primary immune thrombocytopenia

Blood Adv (2019) 3 (22): 3780–3817.

https://doi.org/10.1182/bloodadvances.2019000812

Published: 2019

Includes: Supplemental data

Journal Articles

Markers of autoimmunity in immune thrombocytopenia: prevalence and prognostic significance

Marie A. Hollenhorst, Hanny Al-Samkari, David J. Kuter

Blood Adv (2019) 3 (22): 3515–3521.

https://doi.org/10.1182/bloodadvances.2019000400

Published: 2019

Includes: Supplemental data

Journal Articles

Transient and chronic childhood immune thrombocytopenia are distinctly affected by Fc-γ receptor polymorphisms

David E. Schmidt, Katja M. J. Heitink-Pollé, Annemieke G. Laarhoven, Marrie C. A. Bruin, Barbera Veldhuisen, Sietse Q. Nagelkerke, Taco W. Kuijpers, Leendert Porcelijn, C. Ellen van der Schoot, Gestur Vidarsson, Masja de Haas

Blood Adv (2019) 3 (13): 2003–2012.

https://doi.org/10.1182/bloodadvances.2019000068

Published: 2019

Includes: Supplemental data

Journal Articles

Romiplostim for the management of pediatric immune thrombocytopenia: drug development and current practice

Cindy E. Neunert, Melissa J. Rose

Blood Adv (2019) 3 (12): 1907–1915.

https://doi.org/10.1182/bloodadvances.2019000279

Published: 2019

Journal Articles

Dysregulated megakaryocyte distribution associated with nestin + mesenchymal stem cells in immune thrombocytopenia

Min Wang, Ru Feng, Jia-min Zhang, Lin-lin Xu, Fei-er Feng, Chen-cong Wang, Qian-ming Wang, Xiao-lu Zhu, Yun He, Jing Xue, Hai-xia Fu, Meng Lv, Yuan Kong, Ying-jun Chang, Lan-ping Xu, Kai-yan Liu, Xiao-jun Huang, Xiao-hui Zhang

Blood Adv (2019) 3 (9): 1416–1428.

https://doi.org/10.1182/bloodadvances.2018026690

Published: 2019

Includes: Supplemental data

Journal Articles

Eltrombopag for use in children with immune thrombocytopenia

Taylor Olmsted Kim, Jenny Despotovic, Michele P. Lambert

Blood Adv (2018) 2 (4): 454–461.

https://doi.org/10.1182/bloodadvances.2017010660

Published: 2018

Journal Articles

Misdiagnosis of primary immune thrombocytopenia and frequency of bleeding: lessons from the McMaster ITP Registry

Donald M. Arnold, Ishac Nazy, Rumi Clare, Anushka M. Jaffer, Brandon Aubie, Na Li, John G. Kelton

Blood Adv (2017) 1 (25): 2414–2420.

https://doi.org/10.1182/bloodadvances.2017010942

Published: 2017

Includes: Supplemental data

Journal Articles

ITP and thrombosis: an intriguing association

Francesco Rodeghiero

Blood Adv (2017) 1 (24): 2280.

https://doi.org/10.1182/bloodadvances.2017007989

Published: 2017

Includes: Supplemental data

Journal Articles

Management of newly diagnosed immune thrombocytopenia: can we change outcomes?

Cindy E. Neunert

Blood Adv (2017) 1 (24): 2295–2301.

https://doi.org/10.1182/bloodadvances.2017009860

Published: 2017

NARROW

Spotlight on eltrombopag in pediatric ITP in China: a long-term observational study in real-world practice

Autoimmune- and complement-mediated hematologic condition recrudescence following SARS-CoV-2 vaccination

Misdiagnosed thrombocytopenia in children and adolescents: analysis of the Pediatric and Adult Registry on Chronic ITP

Phase 2 multiple-dose study of an FcRn inhibitor, rozanolixizumab, in patients with primary immune thrombocytopenia

Platelet autoantibodies in the bone marrow of patients with immune thrombocytopenia

Significance of antinuclear antibodies in primary immune thrombocytopenia: results of the CARMEN registry

Risk factors for skin, mucosal, and organ bleeding in adults with primary ITP: a nationwide study in Japan

IVMP+IVIG raises platelet counts faster than IVIG alone: results of a randomized, blinded trial in childhood ITP

A modern reassessment of glycoprotein-specific direct platelet autoantibody testing in immune thrombocytopenia

American Society of Hematology 2019 guidelines for immune thrombocytopenia

Updated international consensus report on the investigation and management of primary immune thrombocytopenia

Markers of autoimmunity in immune thrombocytopenia: prevalence and prognostic significance

Transient and chronic childhood immune thrombocytopenia are distinctly affected by Fc-γ receptor polymorphisms

Romiplostim for the management of pediatric immune thrombocytopenia: drug development and current practice

Dysregulated megakaryocyte distribution associated with nestin + mesenchymal stem cells in immune thrombocytopenia

Eltrombopag for use in children with immune thrombocytopenia

Misdiagnosis of primary immune thrombocytopenia and frequency of bleeding: lessons from the McMaster ITP Registry

ITP and thrombosis: an intriguing association

Management of newly diagnosed immune thrombocytopenia: can we change outcomes?

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only